Go to homepage
€0.00*
Categories
Decode the translatome. Transform medicine.

Technologies for ribosome, coding & non-coding RNA, tRNA and proteome discovery

Simple solutions accessible to all Discover more
double-arrow
Decode the translatome. Transform medicine.

Technologies for ribosome, coding & non-coding RNA, tRNA and proteome discovery






Simple solutions accessible to all Discover more
double-arrow

Our integrated solutions

Products Services

Ribosome Profiling

Products Services

tRNA Sequencing

Services

Translatome Biomarker Discovery

Products Services

In vitro Translation

Products

Proteomics

Services

Data Analysis

About Immagina

Comprehensive translatome platform

The Ribosome Company

Since 2014 that Immagina has been empowering researchers to study the translatome. We often come across scientists that rely solely on transcriptomics and proteomics to understand their biological system. While these provide important data, it is estimated that only 40% of RNA-seq data correlates with the actual proteome.

This is how Immagina first came around to study translation. Seeing this untapped area as an opportunity, Immagina has since built a strong foundation of tools to analyse the translatome, from ribosome profiling (Ribo-seq) to tRNA sequencing and translatome biomarker discovery. Learn more about why we do what we do below.

About us Our technologies

The Ribosome Company

Since 2014 that Immagina has been empowering researchers to study the translatome. We often come across scientists that rely solely on transcriptomics and proteomics to understand their biological system. While these provide important data, it is estimated that only 40% of RNA-seq data correlates with the actual proteome.

This is how Immagina first came around to study translation. Seeing this untapped area as an opportunity, Immagina has since built a strong foundation of tools to analyse the translatome, from ribosome profiling (Ribo-seq) to tRNA sequencing and translatome biomarker discovery. Learn more about why we do what we do below.

About us Our technologies

About Immagina

About Immagina

The Ribosome Company

Since 2014 that Immagina has been empowering researchers to study the translatome. We often come across scientists that rely solely on transcriptomics and proteomics to understand their biological system. While these provide important data, it is estimated that only 40% of RNA-seq data correlates with the actual proteome.

This is how Immagina first came around to study translation. Seeing this untapped area as an opportunity, Immagina has since built a strong foundation of tools to analyse the translatome, from ribosome profiling (Ribo-seq) to tRNA sequencing and translatome biomarker discovery. Learn more about why we do what we do below.

About us Our technologies

The Ribosome Company

Since 2014 that Immagina has been empowering researchers to study the translatome. We often come across scientists that rely solely on transcriptomics and proteomics to understand their biological system. While these provide important data, it is estimated that only 40% of RNA-seq data correlates with the actual proteome.

This is how Immagina first came around to study translation. Seeing this untapped area as an opportunity, Immagina has since built a strong foundation of tools to analyse the translatome, from ribosome profiling (Ribo-seq) to tRNA sequencing and translatome biomarker discovery. Learn more about why we do what we do below.

About us Our technologies

What our costumers say

“Using the ALL-IN-ONE RiboLace Gel-Free Kit, we are able to complete the entire Ribo-seq workflow within three days without the need for ultracentrifugation. In addition, both the experimental protocol and the data analysis pipeline are straightforward and easy to follow. The results have been consistently excellent and highly reproducible. Highly recommended.”

Dr. Yang Yi

Assistant Professor, Northwestern University

Read paper

“The nano-tRNAseq kit does exactly what it promisses. Just followed the exact protocol and was able to get more than enough material for the pooling and sequencing. Highly recommend this straightforward kit to prepare tRNAs for nanopore sequencing”

Dr. Ana Raquel Soares

Assistant Researcher, University of Aveiro

Read paper

“Their translatome approach enabled biomarker discovery...”

Dr. Maria Rossi

University of Milan

Recent news & events

Events

30 October 2026

Upcoming events - november 2026

Upcoming events - November 2026

Join Immagina Biotechnology in November 2026 at RNA conferences, PEGS Europe, and scientific meetings across the US and Europe. Meet our team to explore RNA research, translatomics, and new opportunities for collaboration.

Events

30 September 2026

Upcoming events - october 2026

Upcoming events - October 2026

October takes the Immagina team across Germany, Italy, and the US for a new series of RNA-focused conferences and scientific meetings. See where you can meet us this month.

News

7 September 2026

News_september

Upcoming events - September 2026

September takes the Immagina team across Europe, the US, and Asia for a busy month of RNA, translation, proteomics, and biotechnology events. Meet the team at conferences and research meetings from Newcastle to Singapore.

This website uses cookies to ensure the best experience possible. More information...